Bio-Techne Corp (NASDAQ:TECH) reported its Q4 2024 earnings, surpassing analyst expectations with an EPS of $0.42 against a forecast of $0.39. The company also reported revenue of $297 million, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback